Hello, Fool! | Login | Signup | My Fool
Jan 9, 2009 5:19 PM ET | Feedback | Site Changes | Help
A biotechnology company that develops innovative medicines designed to yield better therapeutic outcomes and improve the lives of patients with serious disease.
View All Commentary (ALKS)
Recs
heniwa (61.93) Submitted: 10/06/06 5:42 PM : Start Price: $15.75 ALKS Score: -0.86
Alkermes has low scientific and regulatory risk, is a preferred partner of large Pharma companies, and has a good pipeline.
Report this Post Replies: 0 | Reply | Permalink
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
Terms & Conditions
RSS Headlines
Fool UK